Moukheibir Catherine — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Moukheibir Catherine has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.15M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-17IRWDIRONWOOD PHARMACEUTICALS INCA — Grant or award63.5K$0.00
2025-07-03MLTXMoonLake ImmunotherapeuticsS — Open-market sale23.5K$48.79$1.15M
2025-07-03MLTXMoonLake ImmunotherapeuticsM — Option exercise23.5K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Moukheibir Catherine?

Moukheibir Catherine is a corporate insider — currently tracked as Director of MoonLake Immunotherapeutics (MLTX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Moukheibir Catherine submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Moukheibir Catherine been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1.15M) across all tracked filings.

Where can I see all of Moukheibir Catherine's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Moukheibir Catherine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.